Production (Stage)
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.74
-$0.09-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.98M | -9.53M | -13.78M | -10.00M | -6.90M |
| Total Depreciation and Amortization | 81.00K | 134.00K | 152.00K | 150.30K | 152.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 76.00K | 132.30K | 188.00K |
| Total Other Non-Cash Items | 1.48M | 1.00M | 1.64M | 283.10K | 78.00K |
| Change in Net Operating Assets | -1.00M | -2.55M | -2.03M | 488.90K | -1.49M |
| Cash from Operations | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.12M | 8.73M | -15.37M | -16.44M | -98.24M |
| Cash from Investing | 18.12M | 8.73M | -15.37M | -16.44M | -98.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -10.90M | -2.27M | -2.32M |
| Issuance of Common Stock | -- | -- | 35.94M | 30.54M | 108.90M |
| Repurchase of Common Stock | -- | -13.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 6.69M | -- |
| Cash from Financing | -- | -13.00K | 25.04M | 34.96M | 106.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.70M | -2.23M | -4.26M | 9.58M | 379.00K |